Delivery Order SPE2DB24D9228-SPE2DB24FATEM
Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $3.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency awarded a $7,571.60 firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the pharmaceutical product NUCALA 100 MG/ML AUTO-INJECTORML. This order was placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency, which has a total potential value of up to $4,999,999 through 2025. The contract enables the DLA to issue delivery orders for a broad range of...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NUCALA 100 MG/ML auto-injectors. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025. This larger contract enables DLA to place delivery orders for a broad range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,678.70 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Nucala 100 mg/ml auto-injectors. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a comprehensive range of pharmaceutical items to fulfill the recurring...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $45,429.60 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NUCALA 100 MG/ML AUTO-INJECTORML. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NUCALA 100 MG/ML AUTO-INJECTOR. The delivery order, with a potential value of $1,892.90, has a performance period through December 27, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NUCALA 100 MG/ML AUTO-INJECTORML. The contract has a completion date of December 20, 2023 and a potential value of $1,892.90. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that supplies a variety of pharmaceutical and medical products to the federal government, particularly the Department of Defense. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $5,678.70 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 4565151275 - NUCALA 100 MG/ML AUTO-INJECTORML. This order was issued under an indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract worth $5,678.70 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of NUCALA 100 MG/ML auto-injectors. This contract has an ultimate completion date of April 11, 2024 and is not associated with any set-aside program. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the SPE2DB program, valued at up...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NUCALA 100 MG/ML auto-injectors. The potential value of this contract is $5,678.70, with a completion date of February 27, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical supplies to U.S. government...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, with a potential value of $11,357.40. The contract is for the provision of NUCALA 100 MG/ML AUTO-INJECTOR medication, with a completion date of February 5, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a wide range of prescription and over-the-counter drug supplies to government...